So far, the majority of studies and clinical trials in ALS have been focused on neurotrophic factors, but also other growth factors have been investigated for their not-so-obvious neurotrophic properties (e.g., vascular endothelial growth factor (VEGF)). Here, VEGFA is linked to amyotrophic lateral sclerosis.